COVID-19 Impact on Global Cerebral Palsy Treatment Market Size, Status and Forecast 2020-2026

August 2020 | 98 pages | ID: C7506130140CEN
QYResearch

Abstracts

This report focuses on the global Cerebral Palsy Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cerebral Palsy Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Pfizer
• GlaxoSmithKline
• Abbott Laboratories
• Allergen
• Merck
• Medtronic
• GW Pharmaceuticals
• Cell Cure Neurosciences
• Acorda Therapeutics
• Meridigen

Market segment by Type, the product can be split into

• Surgery Therapy
• Medication
• Nutrition Therapy
• Others

Market segment by Application, split into

• Hospitals
• Clinics
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Cerebral Palsy Treatment status, future forecast, growth opportunity, key market and key players.
• To present the Cerebral Palsy Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Cerebral Palsy Treatment are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Cerebral Palsy Treatment Revenue
1.4 Market Analysis by Type
  1.4.1 Global Cerebral Palsy Treatment Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Surgery Therapy
  1.4.3 Medication
  1.4.4 Nutrition Therapy
  1.4.5 Others
1.5 Market by Application
  1.5.1 Global Cerebral Palsy Treatment Market Share by Application: 2020 VS 2026
  1.5.2 Hospitals
  1.5.3 Clinics
  1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Cerebral Palsy Treatment Industry Impact
  1.6.1 How the Covid-19 is Affecting the Cerebral Palsy Treatment Industry
    1.6.1.1 Cerebral Palsy Treatment Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Cerebral Palsy Treatment Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Cerebral Palsy Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Cerebral Palsy Treatment Market Perspective (2015-2026)
2.2 Cerebral Palsy Treatment Growth Trends by Regions
  2.2.1 Cerebral Palsy Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Cerebral Palsy Treatment Historic Market Share by Regions (2015-2020)
  2.2.3 Cerebral Palsy Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Cerebral Palsy Treatment Market Growth Strategy
  2.3.6 Primary Interviews with Key Cerebral Palsy Treatment Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Cerebral Palsy Treatment Players by Market Size
  3.1.1 Global Top Cerebral Palsy Treatment Players by Revenue (2015-2020)
  3.1.2 Global Cerebral Palsy Treatment Revenue Market Share by Players (2015-2020)
  3.1.3 Global Cerebral Palsy Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Cerebral Palsy Treatment Market Concentration Ratio
  3.2.1 Global Cerebral Palsy Treatment Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Cerebral Palsy Treatment Revenue in 2019
3.3 Cerebral Palsy Treatment Key Players Head office and Area Served
3.4 Key Players Cerebral Palsy Treatment Product Solution and Service
3.5 Date of Enter into Cerebral Palsy Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Cerebral Palsy Treatment Historic Market Size by Type (2015-2020)
4.2 Global Cerebral Palsy Treatment Forecasted Market Size by Type (2021-2026)

5 CEREBRAL PALSY TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Cerebral Palsy Treatment Market Size by Application (2015-2020)
5.2 Global Cerebral Palsy Treatment Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Cerebral Palsy Treatment Market Size (2015-2020)
6.2 Cerebral Palsy Treatment Key Players in North America (2019-2020)
6.3 North America Cerebral Palsy Treatment Market Size by Type (2015-2020)
6.4 North America Cerebral Palsy Treatment Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Cerebral Palsy Treatment Market Size (2015-2020)
7.2 Cerebral Palsy Treatment Key Players in Europe (2019-2020)
7.3 Europe Cerebral Palsy Treatment Market Size by Type (2015-2020)
7.4 Europe Cerebral Palsy Treatment Market Size by Application (2015-2020)

8 CHINA

8.1 China Cerebral Palsy Treatment Market Size (2015-2020)
8.2 Cerebral Palsy Treatment Key Players in China (2019-2020)
8.3 China Cerebral Palsy Treatment Market Size by Type (2015-2020)
8.4 China Cerebral Palsy Treatment Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Cerebral Palsy Treatment Market Size (2015-2020)
9.2 Cerebral Palsy Treatment Key Players in Japan (2019-2020)
9.3 Japan Cerebral Palsy Treatment Market Size by Type (2015-2020)
9.4 Japan Cerebral Palsy Treatment Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Cerebral Palsy Treatment Market Size (2015-2020)
10.2 Cerebral Palsy Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Cerebral Palsy Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Cerebral Palsy Treatment Market Size by Application (2015-2020)

11 INDIA

11.1 India Cerebral Palsy Treatment Market Size (2015-2020)
11.2 Cerebral Palsy Treatment Key Players in India (2019-2020)
11.3 India Cerebral Palsy Treatment Market Size by Type (2015-2020)
11.4 India Cerebral Palsy Treatment Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Cerebral Palsy Treatment Market Size (2015-2020)
12.2 Cerebral Palsy Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Cerebral Palsy Treatment Market Size by Type (2015-2020)
12.4 Central & South America Cerebral Palsy Treatment Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Pfizer
  13.1.1 Pfizer Company Details
  13.1.2 Pfizer Business Overview and Its Total Revenue
  13.1.3 Pfizer Cerebral Palsy Treatment Introduction
  13.1.4 Pfizer Revenue in Cerebral Palsy Treatment Business (2015-2020))
  13.1.5 Pfizer Recent Development
13.2 GlaxoSmithKline
  13.2.1 GlaxoSmithKline Company Details
  13.2.2 GlaxoSmithKline Business Overview and Its Total Revenue
  13.2.3 GlaxoSmithKline Cerebral Palsy Treatment Introduction
  13.2.4 GlaxoSmithKline Revenue in Cerebral Palsy Treatment Business (2015-2020)
  13.2.5 GlaxoSmithKline Recent Development
13.3 Abbott Laboratories
  13.3.1 Abbott Laboratories Company Details
  13.3.2 Abbott Laboratories Business Overview and Its Total Revenue
  13.3.3 Abbott Laboratories Cerebral Palsy Treatment Introduction
  13.3.4 Abbott Laboratories Revenue in Cerebral Palsy Treatment Business (2015-2020)
  13.3.5 Abbott Laboratories Recent Development
13.4 Allergen
  13.4.1 Allergen Company Details
  13.4.2 Allergen Business Overview and Its Total Revenue
  13.4.3 Allergen Cerebral Palsy Treatment Introduction
  13.4.4 Allergen Revenue in Cerebral Palsy Treatment Business (2015-2020)
  13.4.5 Allergen Recent Development
13.5 Merck
  13.5.1 Merck Company Details
  13.5.2 Merck Business Overview and Its Total Revenue
  13.5.3 Merck Cerebral Palsy Treatment Introduction
  13.5.4 Merck Revenue in Cerebral Palsy Treatment Business (2015-2020)
  13.5.5 Merck Recent Development
13.6 Medtronic
  13.6.1 Medtronic Company Details
  13.6.2 Medtronic Business Overview and Its Total Revenue
  13.6.3 Medtronic Cerebral Palsy Treatment Introduction
  13.6.4 Medtronic Revenue in Cerebral Palsy Treatment Business (2015-2020)
  13.6.5 Medtronic Recent Development
13.7 GW Pharmaceuticals
  13.7.1 GW Pharmaceuticals Company Details
  13.7.2 GW Pharmaceuticals Business Overview and Its Total Revenue
  13.7.3 GW Pharmaceuticals Cerebral Palsy Treatment Introduction
  13.7.4 GW Pharmaceuticals Revenue in Cerebral Palsy Treatment Business (2015-2020)
  13.7.5 GW Pharmaceuticals Recent Development
13.8 Cell Cure Neurosciences
  13.8.1 Cell Cure Neurosciences Company Details
  13.8.2 Cell Cure Neurosciences Business Overview and Its Total Revenue
  13.8.3 Cell Cure Neurosciences Cerebral Palsy Treatment Introduction
  13.8.4 Cell Cure Neurosciences Revenue in Cerebral Palsy Treatment Business (2015-2020)
  13.8.5 Cell Cure Neurosciences Recent Development
13.9 Acorda Therapeutics
  13.9.1 Acorda Therapeutics Company Details
  13.9.2 Acorda Therapeutics Business Overview and Its Total Revenue
  13.9.3 Acorda Therapeutics Cerebral Palsy Treatment Introduction
  13.9.4 Acorda Therapeutics Revenue in Cerebral Palsy Treatment Business (2015-2020)
  13.9.5 Acorda Therapeutics Recent Development
13.10 Meridigen
  13.10.1 Meridigen Company Details
  13.10.2 Meridigen Business Overview and Its Total Revenue
  13.10.3 Meridigen Cerebral Palsy Treatment Introduction
  13.10.4 Meridigen Revenue in Cerebral Palsy Treatment Business (2015-2020)
  13.10.5 Meridigen Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Cerebral Palsy Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Cerebral Palsy Treatment Revenue
Table 3. Ranking of Global Top Cerebral Palsy Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Cerebral Palsy Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Surgery Therapy
Table 6. Key Players of Medication
Table 7. Key Players of Nutrition Therapy
Table 8. Key Players of Others
Table 9. COVID-19 Impact Global Market: (Four Cerebral Palsy Treatment Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Cerebral Palsy Treatment Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Cerebral Palsy Treatment Players to Combat Covid-19 Impact
Table 14. Global Cerebral Palsy Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Cerebral Palsy Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Cerebral Palsy Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Cerebral Palsy Treatment Market Share by Regions (2015-2020)
Table 18. Global Cerebral Palsy Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Cerebral Palsy Treatment Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Cerebral Palsy Treatment Market Growth Strategy
Table 24. Main Points Interviewed from Key Cerebral Palsy Treatment Players
Table 25. Global Cerebral Palsy Treatment Revenue by Players (2015-2020) (Million US$)
Table 26. Global Cerebral Palsy Treatment Market Share by Players (2015-2020)
Table 27. Global Top Cerebral Palsy Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cerebral Palsy Treatment as of 2019)
Table 28. Global Cerebral Palsy Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Cerebral Palsy Treatment Product Solution and Service
Table 31. Date of Enter into Cerebral Palsy Treatment Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Cerebral Palsy Treatment Market Size by Type (2015-2020) (Million US$)
Table 34. Global Cerebral Palsy Treatment Market Size Share by Type (2015-2020)
Table 35. Global Cerebral Palsy Treatment Revenue Market Share by Type (2021-2026)
Table 36. Global Cerebral Palsy Treatment Market Size Share by Application (2015-2020)
Table 37. Global Cerebral Palsy Treatment Market Size by Application (2015-2020) (Million US$)
Table 38. Global Cerebral Palsy Treatment Market Size Share by Application (2021-2026)
Table 39. North America Key Players Cerebral Palsy Treatment Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Cerebral Palsy Treatment Market Share (2019-2020)
Table 41. North America Cerebral Palsy Treatment Market Size by Type (2015-2020) (Million US$)
Table 42. North America Cerebral Palsy Treatment Market Share by Type (2015-2020)
Table 43. North America Cerebral Palsy Treatment Market Size by Application (2015-2020) (Million US$)
Table 44. North America Cerebral Palsy Treatment Market Share by Application (2015-2020)
Table 45. Europe Key Players Cerebral Palsy Treatment Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Cerebral Palsy Treatment Market Share (2019-2020)
Table 47. Europe Cerebral Palsy Treatment Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Cerebral Palsy Treatment Market Share by Type (2015-2020)
Table 49. Europe Cerebral Palsy Treatment Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Cerebral Palsy Treatment Market Share by Application (2015-2020)
Table 51. China Key Players Cerebral Palsy Treatment Revenue (2019-2020) (Million US$)
Table 52. China Key Players Cerebral Palsy Treatment Market Share (2019-2020)
Table 53. China Cerebral Palsy Treatment Market Size by Type (2015-2020) (Million US$)
Table 54. China Cerebral Palsy Treatment Market Share by Type (2015-2020)
Table 55. China Cerebral Palsy Treatment Market Size by Application (2015-2020) (Million US$)
Table 56. China Cerebral Palsy Treatment Market Share by Application (2015-2020)
Table 57. Japan Key Players Cerebral Palsy Treatment Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Cerebral Palsy Treatment Market Share (2019-2020)
Table 59. Japan Cerebral Palsy Treatment Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Cerebral Palsy Treatment Market Share by Type (2015-2020)
Table 61. Japan Cerebral Palsy Treatment Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Cerebral Palsy Treatment Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players Cerebral Palsy Treatment Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players Cerebral Palsy Treatment Market Share (2019-2020)
Table 65. Southeast Asia Cerebral Palsy Treatment Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia Cerebral Palsy Treatment Market Share by Type (2015-2020)
Table 67. Southeast Asia Cerebral Palsy Treatment Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia Cerebral Palsy Treatment Market Share by Application (2015-2020)
Table 69. India Key Players Cerebral Palsy Treatment Revenue (2019-2020) (Million US$)
Table 70. India Key Players Cerebral Palsy Treatment Market Share (2019-2020)
Table 71. India Cerebral Palsy Treatment Market Size by Type (2015-2020) (Million US$)
Table 72. India Cerebral Palsy Treatment Market Share by Type (2015-2020)
Table 73. India Cerebral Palsy Treatment Market Size by Application (2015-2020) (Million US$)
Table 74. India Cerebral Palsy Treatment Market Share by Application (2015-2020)
Table 75. Central & South America Key Players Cerebral Palsy Treatment Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players Cerebral Palsy Treatment Market Share (2019-2020)
Table 77. Central & South America Cerebral Palsy Treatment Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America Cerebral Palsy Treatment Market Share by Type (2015-2020)
Table 79. Central & South America Cerebral Palsy Treatment Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America Cerebral Palsy Treatment Market Share by Application (2015-2020)
Table 81. Pfizer Company Details
Table 82. Pfizer Business Overview
Table 83. Pfizer Product
Table 84. Pfizer Revenue in Cerebral Palsy Treatment Business (2015-2020) (Million US$)
Table 85. Pfizer Recent Development
Table 86. GlaxoSmithKline Company Details
Table 87. GlaxoSmithKline Business Overview
Table 88. GlaxoSmithKline Product
Table 89. GlaxoSmithKline Revenue in Cerebral Palsy Treatment Business (2015-2020) (Million US$)
Table 90. GlaxoSmithKline Recent Development
Table 91. Abbott Laboratories Company Details
Table 92. Abbott Laboratories Business Overview
Table 93. Abbott Laboratories Product
Table 94. Abbott Laboratories Revenue in Cerebral Palsy Treatment Business (2015-2020) (Million US$)
Table 95. Abbott Laboratories Recent Development
Table 96. Allergen Company Details
Table 97. Allergen Business Overview
Table 98. Allergen Product
Table 99. Allergen Revenue in Cerebral Palsy Treatment Business (2015-2020) (Million US$)
Table 100. Allergen Recent Development
Table 101. Merck Company Details
Table 102. Merck Business Overview
Table 103. Merck Product
Table 104. Merck Revenue in Cerebral Palsy Treatment Business (2015-2020) (Million US$)
Table 105. Merck Recent Development
Table 106. Medtronic Company Details
Table 107. Medtronic Business Overview
Table 108. Medtronic Product
Table 109. Medtronic Revenue in Cerebral Palsy Treatment Business (2015-2020) (Million US$)
Table 110. Medtronic Recent Development
Table 111. GW Pharmaceuticals Company Details
Table 112. GW Pharmaceuticals Business Overview
Table 113. GW Pharmaceuticals Product
Table 114. GW Pharmaceuticals Revenue in Cerebral Palsy Treatment Business (2015-2020) (Million US$)
Table 115. GW Pharmaceuticals Recent Development
Table 116. Cell Cure Neurosciences Business Overview
Table 117. Cell Cure Neurosciences Product
Table 118. Cell Cure Neurosciences Company Details
Table 119. Cell Cure Neurosciences Revenue in Cerebral Palsy Treatment Business (2015-2020) (Million US$)
Table 120. Cell Cure Neurosciences Recent Development
Table 121. Acorda Therapeutics Company Details
Table 122. Acorda Therapeutics Business Overview
Table 123. Acorda Therapeutics Product
Table 124. Acorda Therapeutics Revenue in Cerebral Palsy Treatment Business (2015-2020) (Million US$)
Table 125. Acorda Therapeutics Recent Development
Table 126. Meridigen Company Details
Table 127. Meridigen Business Overview
Table 128. Meridigen Product
Table 129. Meridigen Revenue in Cerebral Palsy Treatment Business (2015-2020) (Million US$)
Table 130. Meridigen Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Cerebral Palsy Treatment Market Share by Type: 2020 VS 2026
Figure 2. Surgery Therapy Features
Figure 3. Medication Features
Figure 4. Nutrition Therapy Features
Figure 5. Others Features
Figure 6. Global Cerebral Palsy Treatment Market Share by Application: 2020 VS 2026
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Others Case Studies
Figure 10. Cerebral Palsy Treatment Report Years Considered
Figure 11. Global Cerebral Palsy Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Cerebral Palsy Treatment Market Share by Regions: 2020 VS 2026
Figure 13. Global Cerebral Palsy Treatment Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Cerebral Palsy Treatment Market Share by Players in 2019
Figure 16. Global Top Cerebral Palsy Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cerebral Palsy Treatment as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Cerebral Palsy Treatment Revenue in 2019
Figure 18. North America Cerebral Palsy Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Cerebral Palsy Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Cerebral Palsy Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Cerebral Palsy Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Cerebral Palsy Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Cerebral Palsy Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Cerebral Palsy Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Pfizer Revenue Growth Rate in Cerebral Palsy Treatment Business (2015-2020)
Figure 27. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. GlaxoSmithKline Revenue Growth Rate in Cerebral Palsy Treatment Business (2015-2020)
Figure 29. Abbott Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Abbott Laboratories Revenue Growth Rate in Cerebral Palsy Treatment Business (2015-2020)
Figure 31. Allergen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Allergen Revenue Growth Rate in Cerebral Palsy Treatment Business (2015-2020)
Figure 33. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Merck Revenue Growth Rate in Cerebral Palsy Treatment Business (2015-2020)
Figure 35. Medtronic Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Medtronic Revenue Growth Rate in Cerebral Palsy Treatment Business (2015-2020)
Figure 37. GW Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. GW Pharmaceuticals Revenue Growth Rate in Cerebral Palsy Treatment Business (2015-2020)
Figure 39. Cell Cure Neurosciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Cell Cure Neurosciences Revenue Growth Rate in Cerebral Palsy Treatment Business (2015-2020)
Figure 41. Acorda Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Acorda Therapeutics Revenue Growth Rate in Cerebral Palsy Treatment Business (2015-2020)
Figure 43. Meridigen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Meridigen Revenue Growth Rate in Cerebral Palsy Treatment Business (2015-2020)
Figure 45. Bottom-up and Top-down Approaches for This Report
Figure 46. Data Triangulation
Figure 47. Key Executives Interviewed